JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$817M
| $2.95M | ﹤0.01% |
216,092
| – | – |
2019 Q4
5 quarters
|
|
3302
Seres Therapeutics
MCRB
$29.5M
| $2.94M | ﹤0.01% |
7,150
-585
| -8% | -$269K |
2015 Q2
23 quarters
|
|
|
MRNS
3303
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.94M | ﹤0.01% |
190,093
+27,834
| +17% | +$403K |
2018 Q1
12 quarters
|
|
3304
CALL
Beyond Meat
BYND
$142M
| $2.94M | ﹤0.01% |
+753
| New | +$3.32M |
2021 Q1
0 quarters
|
|
|
AEPPZ
3305
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $2.93M | ﹤0.01% |
60,000
+40,000
| +200% | +$1.93M |
2020 Q3
2 quarters
|
|
|
CTLP
3306
PUT
DELISTED
Cantaloupe
CTLP
| $2.93M | ﹤0.01% |
+250,000
| New | +$2.64M |
2021 Q1
0 quarters
|
|
|
ABTX
3307
DELISTED
Allegiance Bancshares
ABTX
| $2.93M | ﹤0.01% |
72,266
+11,455
| +19% | +$437K |
2016 Q1
20 quarters
|
|
3308
Standard BioTools
LAB
$292M
| $2.92M | ﹤0.01% |
646,808
-565,903
| -47% | -$3.11M |
2016 Q4
17 quarters
|
|
3309
Stock Yards Bancorp
SYBT
$2.44B
| $2.91M | ﹤0.01% |
57,019
-4,521
| -7% | -$217K |
2013 Q2
31 quarters
|
|
3310
CALL
PTC Therapeutics
PTCT
$5.3B
| $2.91M | ﹤0.01% |
+61,400
| New | +$3.65M |
2021 Q1
0 quarters
|
|
|
TPTX
3311
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.91M | ﹤0.01% |
30,723
-16,996
| -36% | -$2.02M |
2019 Q2
7 quarters
|
|
3312
Tootsie Roll Industries
TR
$2.86B
| $2.88M | ﹤0.01% |
100,901
+40,117
| +66% | +$1.1M |
2013 Q2
31 quarters
|
|
3313
Ezcorp Inc
EZPW
$1.86B
| $2.88M | ﹤0.01% |
579,898
-4,631
| -0.8% | -$23.3K |
2016 Q2
19 quarters
|
|
|
FVT
3314
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $2.88M | ﹤0.01% |
+291,600
| New | +$2.91M |
2021 Q1
0 quarters
|
|
3315
Invesco S&P 500 Pure Growth ETF
RPG
$1.96B
| $2.88M | ﹤0.01% |
87,495
-19,120
| -18% | -$632K |
2013 Q2
31 quarters
|
|
|
EGRX
3316
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.87M | ﹤0.01% |
68,722
-6,813
| -9% | -$316K |
2017 Q3
14 quarters
|
|
3317
Scholastic
SCHL
$666M
| $2.87M | ﹤0.01% |
95,198
+32,106
| +51% | +$903K |
2015 Q3
22 quarters
|
|
3318
Sixth Street Specialty
TSLX
$1.72B
| $2.86M | ﹤0.01% |
136,144
+7,189
| +6% | +$154K |
2015 Q2
23 quarters
|
|
3319
Amneal Pharmaceuticals
AMRX
$7.07B
| $2.85M | ﹤0.01% |
424,102
-63,570
| -13% | -$352K |
2018 Q2
11 quarters
|
|
|
ECOL
3320
DELISTED
US Ecology, Inc.
ECOL
| $2.85M | ﹤0.01% |
68,546
+25,669
| +60% | +$999K |
2014 Q4
25 quarters
|
|
|
PGTI
3321
DELISTED
PGT, Inc.
PGTI
| $2.85M | ﹤0.01% |
113,014
-28,554
| -20% | -$670K |
2016 Q1
20 quarters
|
|
3322
iShares Europe ETF
IEV
$1.58B
| $2.84M | ﹤0.01% |
56,602
-5,610
| -9% | -$277K |
2015 Q4
21 quarters
|
|
|
DAO
3323
Youdao
DAO
$1.83B
| $2.84M | ﹤0.01% |
119,225
-126,909
| -52% | -$4.03M |
2019 Q4
5 quarters
|
|
|
POLY
3324
DELISTED
Plantronics, Inc.
POLY
| $2.84M | ﹤0.01% |
72,876
+8,005
| +12% | +$301K |
2014 Q4
25 quarters
|
|
3325
Scholar Rock
SRRK
$5.7B
| $2.83M | ﹤0.01% |
55,921
-4,133
| -7% | -$229K |
2018 Q3
10 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.